@ParadigmBio profile picture
Paradigm Biopharma @ParadigmBio
Joined May 2016
  • Tweets 445
  • Following 242
  • Followers 608
139 Photos and videos
Paradigm secures USD $27M to fully fund its global Phase 3 OA trial through interim analysis. Join today’s investor webinar at 11:30 am AEST: us02web.zoom.us/webinar/regi…

1
2
9
345
Today, Paradigm Biopharmaceuticals announced the acquisition of Proteobioactives, securing global rights to a patented oral combination of PPS and a COX-2 inhibitor, targeting early-stage osteoarthritis in both humans and animals. Read more here: cdn-api.markitdigital.com/ap…
2
224
Paradigm Biopharma retweeted
HotCopper@HotCopper
21 May 2025
This stock could have something close to a cure for #osteoarthritis. Don’t let it hide under your nose Paradigm Biopharmaceuticals (#ASX: $PAR) Managing Director Paul Rennie spoke with The Market Online to discuss further > Find out more: hotcopper.com.au/news/asx-ne… @ParadigmBio
1
2
5
743
We’ve secured centralised US ethics approval for our Phase 3 trial of iPPS in knee osteoarthritis. A significant step in expanding our clinical program and advancing a first-in-class treatment for millions. See Paul Rennie’s comments & full ASX release:cdn-api.markitdigital.com/ap…

2
3
7
229
We're hiring! Paradigm is looking for a Clinical Operations Lead (Hybrid) to manage global trials for our ASX-listed biotech. Apply now 👉 seek.com.au/job/83522919 #BiotechJobs #ClinicalResearch #Hiring #ASX $PAR #PharmaCareers #RemoteWork

1
4
223
Last week, Paradigm presented at the Ignite Investment Summit in Hong Kong. We had incredible engagement from leading family offices across Asia. The strong interest in our phase 3 OA program reaffirms Paradigm as a standout late-stage biotech opportunity. #IgniteConference
1
1
4
230
Paradigm clear to proceed to our pivotal phase three clinical trial in knee osteoarthritis. This is a significant milestone for the company. The team now shifts their focus to the start-up activities to initiate patient enrolment. Read more: cdn-api.markitdigital.com/ap…
8
22
702
Did you catch Tim Boreham's recent article on Paradigm? stockhead.com.au/health/bioc…

Biocurious: Cracking the code on Paradigm’s valuation enigma | Stockhead

The knee osteoarthritis developer is making long-awaited regulatory progress, but selling pressure continues.

stockhead.com.au
2
2
4
455
Paradigm Biopharma retweeted
Stockhead
@StockheadAU
19 Sep 2024
Break it Down: Paradigm Biopharmaceuticals en route to Phase 3 clinical trial with FDA support buff.ly/3Tz86S2 #ASX #ASX200 $PAR @ParadigmBio
2
4
1,051
We are pleased to announce a positive response from the U.S. FDA. 1/3
1
5
447
The FDA's feedback on our phase 2 clinical data confirms the safety and tolerability of our dosing regimen (2mg/kg iPPS administered twice weekly). It offers a clear pathway to move forward with the pivotal phase 3 trial. 2/3
1
1
3
311
This is a significant milestone for Paradigm. You can read more at the link below. cdn-api.markitdigital.com/ap…
3
390
Paradigm's 2024 Annual Report has been released. Key Highlights: - iPPS shows 12-month efficacy - Structural improvements seen at six months - PARA_OA_002 Stage 1 completed Read the full report: cdn-api.markitdigital.com/ap…
1
3
280
Founder and MD, Paul Rennie, presented Paradigm's clinical progress and exciting data to the Bioshares Biotech Summit in Fremantle last week. We would like to thank Mark Pachacz and the wider Bioshares team for the opportunity to present and an outstanding conference. $PAR #ASX
1
8
385
Managing Director, Paul Rennie, will be presenting at the upcoming 18th Bioshares Biotech Summit on Friday 12 July, in Fremantle, Western Australia. $PAR #KneeOA #osteoarthritis #pentosan #PPS
1
5
331
Paradigm Biopharma retweeted
Stockhead
@StockheadAU
25 Jun 2024
#ASX #biotech companies are gunning for US #FDA approval as that not only validates the safety and efficacy of a new drug, but also offers commercial opportunities. bit.ly/4blDSrJ

2
4
3
1,103
Today, we celebrate the achievements of women worldwide, including the incredible contributions of the women at Paradigm. Your dedication is helping to shape the future of care for those suffering from osteoarthritis. Thank you for your invaluable impact on the organisation.
4
462
Arthritis Australia's Senate Inquiry appearance in Feb, spotlighted challenges faced by arthritis patients amid rising costs. CEO Jonathan Smithers stressed staggering out-of-pocket expenses, urging for change and new treatments. Read more: mailchi.mp/arthritisaustrali… $PAR
2
5
664
Today Paradigm received a $7.36 million tax incentive refund. Read more here: cdn-api.markitdigital.com/ap…

1
1
6
1,336
Paradigm released its quarterly activities report with multiple highlights and updates this week. Several key moments are featured below. lnkd.in/dHsY-qwa
0:20
1
4
589
We acknowledge that investors may seek additional clarification regarding this announcement. Kindly direct any inquiries to the following email address: investorrelations@paradigmbiopharma.com
1
227
Load more